601 related articles for article (PubMed ID: 34645459)
21. Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation.
Zhang X; Yang Y; Jing L; Zhai W; Zhang H; Ma Q; Li C; Yan F; Cheng D; Zhang J; Ning Z; Shi H; Wang C; Zhao M; Dai J; Li Z; Ming J; Yu M; Wang H; Cheng H; Xiong H; Dong G
Front Immunol; 2021; 12():680068. PubMed ID: 34025679
[TBL] [Abstract][Full Text] [Related]
22. Conditional knockout of AIM2 in microglia ameliorates synaptic plasticity and spatial memory deficits in a mouse model of Alzheimer's disease.
Ye L; Hu M; Mao R; Tan Y; Sun M; Jia J; Xu S; Liu Y; Zhu X; Xu Y; Bai F; Shu S
CNS Neurosci Ther; 2024 Jun; 30(6):e14555. PubMed ID: 38105588
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
24. The correlation between proteoglycan 2 and neuropsychiatric systemic lupus erythematosus.
Qiao X; Lu L; Zhou K; Tan L; Liu X; Ni J; Hou Y; Liang J; Dou H
Clin Immunol; 2022 Jun; 239():109042. PubMed ID: 35568106
[TBL] [Abstract][Full Text] [Related]
25. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
26. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
Nomura A; Noto D; Murayama G; Chiba A; Miyake S
Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
[TBL] [Abstract][Full Text] [Related]
27.
Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
[TBL] [Abstract][Full Text] [Related]
28. Activation of microglial GPR109A alleviates thermal hyperalgesia in female lupus mice by suppressing IL-18 and glutamatergic synaptic activity.
Viatchenko-Karpinski V; Kong L; Weng HR
Glia; 2022 Apr; 70(4):634-649. PubMed ID: 34919284
[TBL] [Abstract][Full Text] [Related]
29. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.
Shi D; Tian T; Yao S; Cao K; Zhu X; Zhang M; Wen S; Li L; Shi M; Zhou H
Brain Behav Immun; 2018 May; 70():293-304. PubMed ID: 29548997
[TBL] [Abstract][Full Text] [Related]
30. Treatment with 1,25-Dihydroxyvitamin D3 Delays Choroid Plexus Infiltration and BCSFB Injury in MRL/lpr Mice Coinciding with Activation of the PPARγ/NF-κB/TNF-α Pathway and Suppression of TGF-β/Smad Signaling.
Li X; Xu S; Liu J; Zhao Y; Han H; Li X; Wang Y
Inflammation; 2023 Apr; 46(2):556-572. PubMed ID: 36269513
[TBL] [Abstract][Full Text] [Related]
31. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
32. Two-carba cyclic phosphatidic acid treatment promotes phenotypic switch from M1 to M2 microglia and prevents behavioral abnormalities in a mouse model of neuropsychiatric systemic lupus erythematosus.
Nagata W; Gotoh M; Koizumi A; Fukasawa K; Nakagawa K; Satoh Y; Ishizuka T
Hum Cell; 2023 Nov; 36(6):2006-2015. PubMed ID: 37540445
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
34. Sevoflurane induces inflammation of microglia in hippocampus of neonatal rats by inhibiting Wnt/β-Catenin/CaMKIV pathway.
Wang F; Li C; Shao J; Ma J
J Pharmacol Sci; 2021 Jun; 146(2):105-115. PubMed ID: 33941321
[TBL] [Abstract][Full Text] [Related]
35. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus.
Nagata W; Takayama E; Nakagawa K; Koizumi A; Ohsawa Y; Goto H; Yamashiro A; Ishinoda Y; Tanoue K; Kumagai H; Oshima N; Ishizuka T
Clin Exp Rheumatol; 2024 Mar; 42(3):658-665. PubMed ID: 38436267
[TBL] [Abstract][Full Text] [Related]
36. TNF-α regulates microglial activation via the NF-κB signaling pathway in systemic lupus erythematosus with depression.
Kong X; Zhang Z; Fu T; Ji J; Yang J; Gu Z
Int J Biol Macromol; 2019 Mar; 125():892-900. PubMed ID: 30572037
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
[TBL] [Abstract][Full Text] [Related]
38. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.
Alexander JJ; Zwingmann C; Quigg R
Neurochem Int; 2005 Jul; 47(1-2):143-51. PubMed ID: 15893408
[TBL] [Abstract][Full Text] [Related]
39. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
40. Disturbance of neuron-microglia crosstalk mediated by GRP78 in Neuropsychiatric systemic lupus erythematosus mice.
Xu J; Yang C; Zeng S; Wang X; Yang P; Qin L
J Neuroinflammation; 2023 Jun; 20(1):150. PubMed ID: 37365565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
